Mortality, hospice use rates differ in assisted living communities depending on whether memory care is...
By
Kimberly Bonvissuto
Apr 04, 2024
Assisted living communities that provide memory care services may attract residents closer to the end of life or promote hospice use at the end of life compared with assisted living communities without...
Higher education may protect functioning with Alzheimer’s disease
Apr 03, 2024
The findings were seen among African American individuals, with greater protective effect in APOE ɛ4 noncarriers.
Smartphone apps validated as method for detecting Alzheimer’s, new study shows
By
Aaron Dorman
Apr 02, 2024
A smartphone app with memory tests did just as well detecting MCI as when seniors took an in-person medical examination, new research shows.
Signed appropriations package includes $100 million funding increase for dementia research
By
Lois A. Bowers
Mar 25, 2024
A fiscal year 2024 appropriations package signed Saturday by President Biden will increase funding by $100 million for research into Alzheimer’s and other dementias at the National Institutes of Health...
Nearly 7 million Americans have Alzheimer’s, and caregivers are stressed
Mar 20, 2024
Nearly 7 million American seniors are living with Alzheimer’s dementia, placing a huge strain on both personal caregivers and the US healthcare system, according to a new Alzheimer’s Association...
Facility staff and families both struggle to figure out processes for dementia patients, report reveals
By
Kimberly Bonvissuto
Mar 20, 2024
It’s not just family caregivers who face challenges navigating dementia care — the nation’s healthcare workers also said they had difficulties providing care coordination through a complex healthcare...
Light and sound therapy may fend off memory and cognitive damage for chemo patients
By
Aaron Dorman
Mar 08, 2024
A combination of light and sound therapy may be able to counteract the problems in the brain caused by chemo, new research shows.
Timing of CSF biomarker divergence for Alzheimer’s disease, normal cognition varies
Feb 21, 2024
Estimated times of divergence of cerebrospinal fluid biomarkers vary from 18 years for Aβ42 to six years for cognitive decline.
Future of promising Alzheimer’s treatment Leqembi could depend on access to data reporting, analysis:...
By
Aaron Dorman
Feb 16, 2024
Organizations must have clearer guidelines as to how data on lecanemab will be collected, pooled and studied, policy experts say.
Bill calls for $165 million in funding for Alzheimer’s-related initiatives
By
Kimberly Bonvissuto
Feb 12, 2024
Bipartisan bills recently introduced in the US Senate and House of Representatives, if passed as written and signed into law, would fund public health initiatives related to Alzheimer’s disease to the...
